Back to results
CompletedPhase 2

Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer

NCT00017394

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

View on ClinicalTrials.gov
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer — TrialFind